Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Allen Reardon, M.D.

Concepts (796)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with David Reardon's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that David Reardon has written about over time.
Astrocytoma, 17 publications between 2000 and 2015, average publication date November 2008. Antibodies, Monoclonal, 35 publications between 1995 and 2022, average publication date May 2010. Antineoplastic Combined Chemotherapy Protocols, 80 publications between 1991 and 2022, average publication date January 2011. Snake Venoms, 6 publications between 2008 and 2015, average publication date April 2011. Dacarbazine, 50 publications between 1998 and 2023, average publication date August 2011. Glioma, 102 publications between 1998 and 2024, average publication date October 2012. Antineoplastic Agents, 55 publications between 2002 and 2023, average publication date October 2012. Central Nervous System Neoplasms, 16 publications between 2005 and 2022, average publication date February 2013. Angiogenesis Inhibitors, 38 publications between 2006 and 2020, average publication date June 2013. Neoplasm Recurrence, Local, 87 publications between 1999 and 2023, average publication date October 2013. Meningeal Neoplasms, 16 publications between 1999 and 2022, average publication date November 2013. Brain Neoplasms, 239 publications between 1998 and 2024, average publication date February 2014. Antineoplastic Agents, Alkylating, 27 publications between 2003 and 2024, average publication date December 2014. Glioblastoma, 179 publications between 2002 and 2024, average publication date November 2015. Meningioma, 15 publications between 2010 and 2022, average publication date December 2015. Cancer Vaccines, 19 publications between 2008 and 2024, average publication date July 2016. Immunotherapy, 39 publications between 2002 and 2024, average publication date January 2018.

To see the data from this visualization as text, click here.
Reardon's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (796)
Explore
_
Co-Authors (216)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.